Education
About Us
Working with TipRanks
Follow Us
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 583.23K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 576.18K | $ -186.44K | $ -271.68K | $ -229.61K |
| Operating Income | $ -14.32M | $ -15.47M | $ 38.18M | $ -38.04M | $ -52.15M |
| EBITDA | $ -14.32M | $ -14.28M | $ -112.48M | $ -36.86M | $ -53.25M |
| Net Income | $ -12.96M | $ -14.29M | $ -224.88M | $ -36.54M | $ -53.92M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 22.85M | $ 21.61M | $ 28.79M | $ 53.08M | $ 89.02M |
| Total Assets | $ 23.98M | $ 22.65M | $ 30.16M | $ 56.82M | $ 92.81M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 190.47K | $ 335.16K |
| Net Debt | $ -22.85M | $ -21.61M | $ -28.79M | $ -52.89M | $ -88.68M |
| Total Liabilities | $ 4.67M | $ 5.70M | $ 4.51M | $ 7.32M | $ 15.41M |
| Stockholders' Equity | $ 19.31M | $ 18.26M | $ 25.64M | $ 49.51M | $ 77.40M |
| Cash Flow | |||||
| Free Cash Flow | $ -13.57M | $ -12.27M | $ -25.01M | $ -37.69M | $ -41.83M |
| Operating Cash Flow | $ -13.56M | $ -12.18M | $ -25.01M | $ -37.69M | $ -41.80M |
| Investing Cash Flow | $ -15.48K | $ -93.09K | $ 0.00 | $ 0.00 | $ -25.71K |
| Financing Cash Flow | $ 14.82M | $ 5.14M | $ 682.97K | $ 1.75M | $ 150.95K |